GlassScriptPhysician profile
Keith G Porter
NPI 1821036179
$1,417.60
in general payments reported to CMS, 2019-2025
17 companies · $19.41 in 2025
The $19.41 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $461 · 2020: $318 · 2021: $271 · 2022: $58.44 · 2023: $86.42 · 2024: $203 · 2025: $19.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $289 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.00 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $297.88 | 2019-2024 | Xarelto |
| Pfizer INC. | $286.99 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $171.38 | 2019-2021 | |
| Ucb, INC. | $125.88 | 2019-2020 | |
| Novo Nordisk INC | $92.59 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $79.70 | 2022-2024 | Eliquis |
| Csl Behring | $60.69 | 2019-2024 | Kcentra |
| Novartis Pharmaceuticals Corporation | $54.52 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $51.97 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.60 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $33.01 | 2023 | Xarelto |
| Portola Pharmaceuticals, LLC | $29.11 | 2019-2020 | |
| Abbott Laboratories | $20.90 | 2024 | Cardiomems |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.43 | 2024 | Xifaxan |
| Vertex Pharmaceuticals Incorporated | $19.41 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $16.69 | 2020 | |
| Allergan, INC. | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.